A substantial proportion of overall risk may be preventable by healthy lifestyle.,/p>
CV, cancer risk up with tofacitinib for rheumatoid arthritis
Jan 28, 2022
Incidences of major adverse cardiovascular events and cancers were higher with tofacitinib versus a TNF inhibitor; criteria for noninferiority were not met.
Skyrizi approved for psoriatic arthritis
Jan 26, 2022
The approval was based on two Phase 3 trials showing that more than 50% of patients receiving Skyrizi achieved an ACR20 response at 24 weeks.
Fatigue common even with early rheumatoid arthritis
Jan 25, 2022
Those presenting with fatigue early were likely to see it persist.
MRI of hand, foot may predict rheumatoid arthritis in undifferentiated arthritis
Jan 24, 2022
MRI-detected tenosynovitis was independently associated with progression to rheumatoid arthritis.
Duloxetine does not alleviate pain in chronic osteoarthritis
Jan 06, 2022
No differences was seen in Western Ontario and McMaster Universities Arthritis Index pain at three or 12 months with duloxetine added to usual care, or in subgroup with symptoms of centralized pain.
Hyaluronic acid injection use increased for knee osteoarthritis in seniors
Dec 23, 2021
A significant increase in utilization and associated costs was seen among physicians’ assistants and nurse practitioners.
Serum biomarkers can differentiate psoriatic arthritis, RA
Dec 21, 2021
A panel of serum protein biomarkers was identified and evaluated for potential use in diagnostic testing for early-onset psoriatic arthritis.
Subclinical synovitis may precede arthritis in anti-CCP2+ individuals
Dec 21, 2021
Anti-CCP3 antibodies were predictive for the development of ultrasound synovitis in anti-CCP2+ at-risk individuals
Platelet-rich plasma injections do not ease pain in knee osteoarthritis
Dec 03, 2021
No difference was seen in change in median tibial cartilage volume at 12 months for platelet-rich plasma versus saline placebo injections.